复方丹参片为临床常用药物，生产厂家众多。
Danshen tablets used for clinical medicine, many manufacturers.
目的：全面评价复方丹参片等复方丹参制剂的质量。
Objective: To study the compound Tanshen tablet for its overall quality assessment.
目的观察复方丹参片治疗慢性浅表性胃炎的临床疗效。
Objective To observe the effect of Danshen tablets treatment on chronic superficial gastritis.
在制备工艺、质量控制、临床观察等方面均优于复方丹参片。
The Compound Danshen Capsules made by novel preparation process are superior to Compound Danshen Tablets in respects of preparation pro - cess, quality control and clinical observation.
本文对近年来有关复方丹参片质量考察的文献进行了综述，现报道如下。
This paper reviews the literature in recent years about the quality of Danshen tablet inspection, and now it is reported as follows.
结论复方丹参片降低兴奋性氨基酸含量，以对抗兴奋性氨基酸的毒性，这可能是其防治ad的机制之一。
Conclusion CDST could lower the toxicity of excitatory amino acid by decreasing its contents, which may be one of the mechanisms of CDST in prevention and treatment to AD.
由于在药典2000版之前，均未制定含量测定方法，因此对市售的复方丹参片的内在质量进行考核是有必要的。
As the pharmacopoeia in 2000 until the determination not to develop, the market for films salvia compound of the intrinsic quality of the examination is necessary.
目的观察复心片与复方丹参滴丸治疗冠心病稳定型心绞痛的临床疗效，并对其安全性作出评价。
Objective to investigate the curative effect of Fuxin tablets and compound Danshen Dripping pills (DSP) on stable angina pectoris and to evaluate their security.
目的：建立复方丹参缓释片多指标成分的体外释放度测定方法，评价其体外释药行为。
Objective: to develop the methods to determine the in vitro release of multi-target ingredients in Compound Danshen Sustained-release Tablets and to evaluate its release behavior in vitro.
结论：复方丹参滴丸是一种安全有效治疗冠心病心绞痛的药物，较丹参片疗效好。
CONCLUSION: Composite Salvia Dropping Pill is a safe and effective drug for treatment of angina pectoris.
目的：比较复方丹参滴丸与丹参片治疗冠心病心绞痛的疗效。
AIM: to observe the efficacy of Composite Salvia Dropping Pill in the treatment of angina pectoris and myocardial ischemia.
目的：比较复方丹参滴丸与丹参片治疗冠心病心绞痛的疗效。
AIM: to observe the efficacy of Composite Salvia Dropping Pill in the treatment of angina pectoris and myocardial ischemia.
应用推荐